Skip to Main Content

Paper Details

Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis.
Blood Adv
51
2020
Author NameAffiliation
Moshe TalpazComprehensive Cancer Center, University of Michigan ann arbor
Stephen T OhWashington University School of Medicine
  • 1 - 2

Datasets

Release 1.2